Overview
- 30 inspections across 30 sites are on record.
- 25 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-09-03.
At a glance
Inspections
30
Sites
30
Observations
25
Career since
Jun 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| MSD International GmbH (Singapore Branch) | 3 Sep 2021 | Human Drugs | On file |
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 21 Apr 2021 | Human Drugs | On file |
| Chugai Pharma Manufacturing Co., Ltd | 21 Feb 2020 | Human Drugs | On file |
| GP PHARM S.A.U. | 21 May 2019 | Human Drugs | View 483 → |
| Immunex Rhode Island Corporation | 19 Apr 2019 | Human Drugs | On file |
Sites inspected
MSD International GmbH (Singapore Branch)Singapore, Singapore1 insp.
FujiFilm Diosynth Biotechnologies U.S.A., Inc.Research Triangle Park, United States1 insp.
Chugai Pharma Manufacturing Co., LtdUtsunomiya, Japan1 insp.
GP PHARM S.A.U.Sant Quinti De Mediona, Spain1 insp.
Immunex Rhode Island CorporationWest Greenwich, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Wayne E Seifert3 shared
Haripada Sarker3 shared
Caryn M Mcnab3 shared
Cheryl A Clausen2 shared
Zhong Li2 shared
Ephrem T Hunde2 shared
Thuy T Nguyen2 shared
Laura Fontan2 shared
Yun Wu1 shared
Jacek Cieslak1 shared
Full investigator report
Get the verbatim findings behind Zhihao Pete Qiu's 25 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site